The AMA is committed to enhancing physicians’ efforts to help end the nation’s drug overdose epidemic. We encourage policymakers to use AMA recommendations for evidence-based care in their work to help end the epidemic.
The American Medical Association Substance Use and Pain Care Task Force highlights progress in addressing the drug overdose epidemic, including increased harm reduction efforts, access to naloxone, and reductions in mortality, while emphasizing the need for better policies to address inequities and improve access to me
Read more >
February 6, 2024
The American Medical Association (AMA) and Manatt have developed recommendations for policymakers to improve access to care for pregnant and postpartum people with opioid use disorder, focusing several strategies on justice-involved individuals.
Read more >
November 8, 2023
Opioid prescribing continues downward trend while overdose and death related to illicitly manufactured fentanyl, methamphetamine and cocaine increase.
Read more >December 12, 2022
“The fight to end the nation’s overdose epidemic and restore compassionate care: Profiles in leadership.” Read more how a select group of physicians, policymakers and patient advocates exemplify proven policies and actions that help save lives and improve outcomes for people with substance use disorders, patients with pain, and those who need harm reduction services.
Read more >
September 7, 2022
Opioid prescribing continues downward trend while overdose and death related to illicitly manufactured fentanyl, methamphetamine and cocaine increase.
Read more >
February 4, 2022
The AMA and Manatt Health 2022 State Toolkit identifies more than 400 state laws, regulations, policy guidance and other select national actions being implemented to help end the nation’s drug overdose epidemic. We encourage all states to use this resource as a go-to guide to increase access to evidence-based treatment and save lives from overdose.
Read more >
September 20, 2021
AMA calls on policymakers and others to remove barriers to evidence-based care for patients with pain and those with a substance use disorder.
Read more >
December 16, 2020
This report provides leading-edge examples and best practices from more than 25 states. Policymakers and others can use these and the report’s tangible recommendations to take meaningful action to help patients access evidence-based treatment for substance use disorders, comprehensive pain care, and proven harm reduction strategies.
Read more >
July 20, 2020
Sharp reductions in prescription opioid supply, continued increases in PDMP use, but staggering increase in fatalities involving illicit opioids, methamphetamine, heroin and cocaine were demonstrated in 2019.
Read more >
June 12, 2020
The 2019 progress report highlights physician action and the immediate need for policymakers to focus on removing barriers to evidence-based treatment.
Read more >
June 12, 2020
Leading-edge Practices and Next Steps.
Read more >
May 15, 2019
Analyzing substance use disorder treatment, pain management and harm reduction.
Read more >
May 15, 2019
Best practices and recommendations for ending the opioid epidemic in Mississippi.
Read more >
January 15, 2019
Colorado’s progress and recommended next steps to end the opioid epidemic.
Read more >
December 15, 2018
Pennsylvania makes for an ideal case study on how strong leadership can make a difference—even if the fight is not over yet.
Read more >
June 12, 2018
Physicians’ progress to reverse the nation’s opioid epidemic.
Read more >
Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.